Viewing data from:

LOFEXIDINE HYDROCHLORIDE

ANDA

LOFEXIDINE HYDROCHLORIDE | A218699 | MSN LABORATORIES PRIVATE LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: LUCEMYRA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$9.48

per ea

Lowest NADAC/Unit

$9.48

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
72205024642LOFEXIDINE 0.18 MG TABLET	$9.48	EA	Generic	—	2026-06-17
72205024643LOFEXIDINE 0.18 MG TABLET	$9.48	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

MSN LABORATORIES PRIVATE LTDLOFEXIDINE HYDROCHLORIDE

DMF 346362020

PROCOS SPALOFEXIDINE HYDROCHLORIDE

DMF 375432022

MEDICHEM MANUFACTURING (MALTA) LTDLOFEXIDINE HYDROCHLORIDE

DMF 379782023

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 0.18MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 24, 2025

No patent or exclusivity listings for this strength.